Identifying and controlling for program-level differences in comparative cost analysis: Lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program

Evaluation and Program Planning

Volumn 31, Issue 2, 2008, Pages 136-144

  Subramanian, Sujha ^a   Ekwueme, Donatus U ^b   Gardner, James G ^b   Bapat, Bela ^a   Kramer, Caren ^a  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Breast cancer; Cancer screening; Cervical cancer; Cost of cancer screening; Economic evaluation

Indexed keywords

CANCER; COST-BENEFIT ANALYSIS; HEALTH CARE; METHODOLOGY;

ARTICLE; BREAST TUMOR; COST; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HUMAN; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; UNITED STATES; UTERINE CERVIX TUMOR;

BREAST NEOPLASMS; COSTS AND COST ANALYSIS; EARLY DIAGNOSIS; FEMALE; HUMANS; MASS SCREENING; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 42049101200     PISSN: 01497189     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.evalprogplan.2008.02.002     Document Type: Article

References (21)

1. Baicker K., and Chandra A. Medicare spending, the physician workforce, and beneficiaries quality of care. Health Affairs (2004) W4-184-W4-197
2. Benard V.B., Eheman C.R., Lawson H.W., Blackman D.K., Anderson C., Helsel W., et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstetrics & Gynecology 103 3 (2004) 564-571
3. Benson K., and Hartz A.J. A comparison of observation studies and randomized, controlled trials. New England Journal of Medicine 342 (2000) 1878-1886
4. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observation studies, and the hierarchy of research designs. New England Journal of Medicine 342 (2000) 1887-1892
5. Diez-Roux A.V. Multilevel analysis in public health research. Annual Review of Public Health 21 (2000) 171-192
6. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., and Stoddart G.J. Methods for the economic evaluation of health care programme. 3rd ed. (2005), Oxford University Press, Oxford, England
7. Eheman C.R., Benard V.B., Blackman D., Lawson H.W., Anderson C., Helsel W., et al. Breast cancer screening among low-income or uninsured women: Results from the National Breast and Cervical Cancer Early Detection Program. Cancer Causes and Control 17 1 (2006) 29-38
8. French M.T., Dennis M.L., McDougal G.L., Karuntzos G.T., and Hubbard R.L. Training and employment programs in methadone treatment: Client needs and desires. Journal of Substance Abuse Treatment 9 12 (1992) 293-303
9. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., and McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment 5 (1997) 445-455
10. French M.T., Roebuck M.C., and McLellan A.T. Cost estimation when time and resources are limited: The brief DATCAP. Journal of Substance Abuse Treatment 3 (2004) 187-193
11. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York, NY
12. Greenland G., and Morgenstern H. Confounding in health research. Annual Review of Public Health 22 (2001) 189-212
13. Haddix A.C., Teutsch S.M., and Corso P.A. Prevention effectiveness: A guide to decision analysis and economic evaluation. 2nd ed. (2003), Oxford University Press, New York, NY
14. Iezzoni L.I. Risk adjusting rehabilitation outcomes: An overview of methodologic issues. American Journal of Physical Medicine and Rehabilitation 83 4 (2004) 316-326
15. Keenan P.S., Buntin M.B., McGuire T.G., and Newhouse J.P. The prevalence of formal risk adjustment in health plan purchasing. Inquiry 38 3 (2001) 245-259
16. Leonard, H. B., & Walder, J. H. (2000). The federal budget and the states: Fiscal year 1999, 15 December 2000. Retrieved November 17, 2006 from 〈http://www.ksg.harvard.edu/taubmancenter/pdfs/fisc/complete_99.pdf 〉.
17. Mansley E.C., Dunet D.O., May D.S., Chattopadhaya S.K., and McKenna M.T. Variations in average costs among federally sponsored state-organized cancer detection programs: Economics of scale?. Medical Decision Making 22 (2002) S67-S79
18. PART (2006). Program Assessment Rating Tool (PART). Retrieved November 17, 2006 from 〈http://www.whitehouse.gov/omb/part/fy2006/2006_guidance_final. pdf〉.
19. Ryerson A.B., Benard V.B., and Major A.C. National Breast and Cervical Cancer Early Detection Program: 1991-2002 national report (2005), Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA: U.S. (Retrieved January 10, 2007 from) 〈http://www.cdc.gov/cancer/nbccedp/Reports/NationalReports/index.ht m〉
20. Salome H.J., French M.T., Miller M., and McLellan A.T. Estimating the client costs of addiction treatment: First findings from the Client Drug Abuse Treatment Cost Analysis Program (Client DATCAP). Drug and Alcohol Dependency 71 2 (2003) 195-206
21. Winship C., and Morgan S.L. The estimation of causal effects from observational data. Annual Review of Sociology 25 (1999) 659-706